Zentek Ltd.

NASDAQ:ZTEK

Other Precious Metals

Basic Materials
$0.49 +25.56%

+$0.10 today

Market cap
$62.30M
Beta
0.47
P/E (TTM)
-9.6
EPS (TTM)
-$0.08
52W Low $0.37High $1.34

Volume 0.93M

Average 0.15M

ZTEK Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Zentek Ltd.NASDAQ: ZTEK

Cost of Revenue · Q4 FY2025 · quarter ended Mar 2026

Cost of revenue growth accelerates

Q4 FY2025 cost of revenue of CA$2.98M rose 1012.6% year over year, ahead of the +545.4% change in trailing-twelve-month cost of revenue. Sequentially, it rose 121.8% from the prior quarter. Over 3 fiscal years it compounded at +96.4% a year.

Context

  • Cost of revenue amounted to 3885.5% of revenue in FY2025, up 3807.5 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1012.6% holds above the trailing-twelve-month pace of +545.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$2.98M+121.8% QoQ
Last fiscal yearMar 2026
CA$6.47M+851.2% YoY
LTMMar 2026
CA$4.36M+545.4% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1012.6%——
1 year+851.2%——
3-year CAGR+96.4%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

CAD · from the income statement

Latest · FY2025
6.47M CAD
Year-over-year change
+851.2%
4-year CAGR
+103.6%

Cost of Revenue vs competitors

How ZTEK compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +545.4% is the highest of 8, against a peer median of -18.9%.
  • Cost of revenue amounts to 2622.4% of revenue for ZTEK, versus a peer median of 49.5%.
ZTEK Competitors
Cost of Revenue for ZTEK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMWLAmerican Well CorporationLTM Mar 2026$119.38M USD-18.1%-10.1%50.3%
HYPRHyperfine, Inc.LTM Mar 2026$7.48M USD+18.5%+4.9%48.8%
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$7.28M CAD-18.9%+9.4%39.7%
ZTEKZentek Ltd.LTM Mar 2026CA$4.36M CAD+545.4%+96.4%2622.4%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$150K USD-31.8%——
MBOTMicrobot Medical Inc.LTM Mar 2026$115K USD+342.3%—109.5%
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$52.73K CAD-33.2%——
BYSIBeyondSpring Inc.LTM Mar 2026$19K USD———
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD-100.0%——
Peer median (excluding ZTEK) —-18.9%+4.9%49.5%

Competitors are the stored peer set for ZTEK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue339.67K72.86K29.82K872.5K166.48K
Cost of Revenue376.79K853.34K331.08K680.01K6.47M
Gross Profit(37.12K)(780.48K)(301.26K)192.49K(6.3M)
Gross Margin-10.9%-1071.3%-1010.4%22.1%-3785.5%
Research & Development1.54M1.65M1.78M465.65K1.66M
Selling, General & Admin9.56M10.99M8.95M8.01M2.87M
Operating Expenses12.53M13.87M11.68M9.79M4.56M
Depreciation & Amortization614.71K539.69K613.71K600.32K527.77K
EBITDA(31.02M)(13.75M)(11.08M)(9.35M)(10.33M)
EBITDA Margin-9131.2%-18878.5%-37170.3%-1071.4%-6204.7%
Operating Income(12.56M)(14.65M)(11.98M)(9.6M)(10.86M)
Operating Margin-3698.5%-20112.5%-40174.8%-1100.4%-6521.7%
Interest Income20.6K510.26K405.48K101.61K40.41K
Interest Expense63.78K120.62K107.37K91.32K289.98K
Other Income / Expenses(19.13M)238.68K174.74K(439.03K)1.06M
Income Before Tax(31.69M)(14.41M)(11.8M)(10.04M)(9.79M)
Pre-Tax Margin-9330.9%-19784.9%-39588.7%-1150.7%-5882.6%
Income Tax Expense00(99.78K)00
Net Income(31.69M)(14.41M)(11.7M)(10.04M)(9.79M)
Net Margin-9330.9%-19784.9%-39254.1%-1150.7%-5882.6%
EPS (Basic)(0.42)(0.14)(0.12)(0.10)(0.09)
EPS (Diluted)(0.42)(0.14)(0.12)(0.10)(0.09)
Weighted Avg Shares92.09M99.44M97.53M102.98M105.92M
Weighted Avg Shares (Diluted)92.09M99.44M100.5M102.98M105.92M

Zentek Ltd.

NASDAQ:ZTEK

Intrinsic Alpha fair value

Locked

Current Price

$0.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.